Similar articles for PMID: 12464360

Year	Number of Results
1985	1
1986	1
1992	1
1994	1
1995	4
1996	6
1997	2
1998	2
1999	5
2000	7
2001	11
2002	13
2003	14
2004	5
2005	1
2006	3
2007	1
2008	3
2009	1
2010	4
2011	2
2012	2
2013	1
2014	1
2016	1
2019	1
2020	1
2024	0

1

Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.

De Vry J, Rüdiger Jentzsch K. De Vry J, et al. Eur J Pharmacol. 2002 Dec 20;457(2-3):147-52. doi: 10.1016/s0014-2999(02)02697-3. Eur J Pharmacol. 2002. PMID: 12464360

2

Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.

De Vry J, Jentzsch KR. De Vry J, et al. Eur J Pharmacol. 2004 Nov 28;505(1-3):127-33. doi: 10.1016/j.ejphar.2004.10.012. Eur J Pharmacol. 2004. PMID: 15556145

3

Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.

Mauler F, Mittendorf J, Horváth E, De Vry J. Mauler F, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):359-68. doi: 10.1124/jpet.302.1.359. J Pharmacol Exp Ther. 2002. PMID: 12065738

4

Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.

McMahon LR. McMahon LR. J Pharmacol Exp Ther. 2006 Dec;319(3):1211-8. doi: 10.1124/jpet.106.107110. Epub 2006 Aug 30. J Pharmacol Exp Ther. 2006. PMID: 16943255

5

Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.

Meschler JP, Kraichely DM, Wilken GH, Howlett AC. Meschler JP, et al. Biochem Pharmacol. 2000 Nov 1;60(9):1315-23. doi: 10.1016/s0006-2952(00)00447-0. Biochem Pharmacol. 2000. PMID: 11008125

6

Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.

De Vry J, Jentzsch KR. De Vry J, et al. Eur J Pharmacol. 1998 Sep 11;357(1):1-8. doi: 10.1016/s0014-2999(98)00503-2. Eur J Pharmacol. 1998. PMID: 9788767

7

(R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.

Järbe TU, Lamb RJ, Liu Q, Makriyannis A. Järbe TU, et al. Eur J Pharmacol. 2003 Apr 11;466(1-2):121-7. doi: 10.1016/s0014-2999(03)01491-2. Eur J Pharmacol. 2003. PMID: 12679148

8

Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.

Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R. Fride E, et al. Eur J Pharmacol. 2003 Feb 7;461(1):27-34. doi: 10.1016/s0014-2999(03)01295-0. Eur J Pharmacol. 2003. PMID: 12568912

9

Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.

Norwood CS, Cornish JL, Mallet PE, McGregor IS. Norwood CS, et al. Eur J Pharmacol. 2003 Mar 28;465(1-2):105-14. doi: 10.1016/s0014-2999(03)01455-9. Eur J Pharmacol. 2003. PMID: 12650839

10

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.

Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F. Izzo AA, et al. Eur J Pharmacol. 1999 Nov 12;384(1):37-42. doi: 10.1016/s0014-2999(99)00673-1. Eur J Pharmacol. 1999. PMID: 10611417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year